{"title": "Stephen Hauser  UCSF Profiles", "author": null, "url": "https://profiles.ucsf.edu/stephen.hauser", "hostname": "ucsf.edu", "description": "Stephen Hauser's profile, publications, research topics, and co-authors", "sitename": "UCSF", "date": "2000-08-01", "cleaned_text": "- Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab. Eur J Neurol. 2023 Jul 24. Puig-Casadevall M, in: [PubMed](https://www.ncbi.nlm.nih.gov/pubmed/37485841) Mentions: of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment. Neurol Ther. 2023 Jul 14. Hauser SL, Kappos L, Bar-Or A, Wiendl H, Paling D, Williams M, Gold R, Chan A, Milo R, Das Gupta A, Karlsson G, Sullivan R, Graham G, Merschhemke M, P. neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosis. medRxiv. 2023 Jul 03. Chitnis T, predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase EBioMedicine. A, Thanei GA, Harp C, Bernasconi C, Bonati U, Cross AH, Fischer S, Gaetano L, Hauser SL, Hendricks R, Kappos L, Kuhle J, Leppert D, Model F, EL, - epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types genes. Commun of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2023 03; 10(2). Hauser Kletzl H, G\u00fcnther A, Manfrini M, Model F, Mercier F, Petry C, Wing Q, H, association with multiple sclerosis susceptibility and phenotype in Europeans. Brain. 2023 02 13; 146(2):645-656. Shams H, Shao X, Santaniello A, Kirkish G, Harroud A, [Ma Q](https://profiles.ucsf.edu/qin.ma), Isobe N, University of California San MS-EPIC McCauley JL, Cree [Dandekar R](https://profiles.ucsf.edu/ravi.dandekar), Wu Guo CY, Romeo AR, Cree BA, UCSF MS-EPIC Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosis. Mult Scler. 2023 Khan measures shown by structural MRI: a post-hoc analysis of a smartphone-based remote assessment feasibility study in multiple sclerosis. J Neurol. Mar; T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19. Science. 2022 04 15; 376(6590):eabi9591. Li J, Zaslavsky M, Su Y, Guo J, Sikora MJ, van Unen V, Christophersen A, Chiou SH, Chen L, Li J, Ji X, Wilhelmy J, McSween AM, Palanski BA, Mallajosyula VVA, GKR, Bhamidipati K, LB, Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple TJ, R, Santaniello A, Consortium S, Ayoubi NE, Cree BAC, Hauser SL, H, Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials. Front Immunol. 2022; 13:852563. Ziemssen T, Arnold DL, Alvarez E, Cross AH, Willi R, Li B, Kukkaro P, Kropshofer H, Ramanathan K, Merschhemke M, Kieseier B, Su W, of S](https://profiles.ucsf.edu/simone.sacco), Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results Hauser Cohen JA, Cross AH, Deiva K, Ganjgahi H, H\u00e4ring DA, Li B, Pingili R, Ramanathan K, regional distributions of atrophy across the neuraxis in MS continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years. Mult Scler. 2022 09; 28(10):1576-1590. Hauser SL, Cross Nicholas J, Meuth SG, Giacomini PS, Sacc\u00e0 F, Mancione L, Zielman R, Bagger M, Das Gupta A, H\u00e4ring DA, Jehl V, Kieseier BC, Pingili R, Stoneman SPAST knockout human induced pluripotent stem cell lines to create a model for Hereditary Spastic Paraplegia type 4. Stem Cell Res. 2022 04; a Precision Medicine Delivery Platform for Clinics: The University of California, San Francisco, BRIDGE Experience. J Med Internet Res. 2022 02 Ahrens M, Alispach C, Alves AA, Amin NM, An R, Andeen K, Anderson T, Anton G, Arg\u00fcelles C, Ashida Y, Axani S, Bai X, Barwick SW, [Bastian B](https://profiles.ucsf.edu/boris.bastian), Basu V, Baur S, R, JJ, KH, Becker Tjus J, Bellenghi C, BenZvi Bontempo S, Botner E, Bradascio F, Braun J, Bron S, Brostean-Kaiser J, Browne S, A, Burley RT, Busse RS, Campana MA, Carnie-Bronca EG, Chen C, Chen Z, Chirkin D, Choi K, Clark BA, Clark K, Classen L, Coleman A, Collin GH, Conrad JM, Coppin P, Correa P, Cowen DF, Cross R, Dappen C, Dave P, De Clercq C, DeLaunay JJ, Dembinski H, Deoskar K, Desai A, Desiati P, de Vries KD, de Wasseige G, de With M, DeYoung T, Dharani S, Diaz A, D\u00edaz-V\u00e9lez JC, Dittmer M, DuVernois E, Ehrhardt T, Eller P, Engel R, Erpenbeck H, Evans J, Evenson PA, Fan KL, Fazely AR, Feigl N, Fiedlschuster S, Fienberg AT, Filimonov K, Finley C, Fischer L, Fox D, Franckowiak A, Friedman E, Fritz A, F\u00fcrst P, Gaisser TK, Gallagher J, Ganster E, Garcia A, Garrappa S, Gerhardt L, Ghadimi A, Glaser C, Glauch T, Gl\u00fcsenkamp T, Gonzalez JG, Goswami S, Grant D, Gr\u00e9goire T, Griswold S, G\u00fcnd\u00fcz M, G\u00fcnther C, Haack C, Hallgren A, Halliday R, Halve L, Halzen F, Ha Minh M, Hanson K, Hardin J, Harnisch AA, Haungs A, Hauser S, Hebecker K, Henningsen F, Hettinger EC, Hickford S, Hignight J, Hill C, Hill GC, Hoffman KD, Hoffmann R, Hoinka T, Hokanson-Fasig B, Hoshina K, Huang F, Huber M, Huber T, Hultqvist K, H\u00fcnnefeld M, Hussain R, In S, Iovine N, Ishihara A, Jansson M, Japaridze GS, Jeong M, Jones BJP, Kang D, Kang W, Kang X, Kappes A, Kappesser D, Karg T, Karl M, Karle A, Katz U, Kauer M, Kellermann M, Kelley JL, Kheirandish A, Kin K, Kintscher T, Kiryluk J, Klein Koirala R, Kolanoski M, Kowalski M, T, Lanfranchi JL, Larson Lauber F, Lazar Lee JW, Leonard K, Leszczynska A, Li Y, Lincetto M, Liu QR, R, Mase K, McElroy T, McNally F, Mead JV, Meagher K, Mechbal S, Medina A, Meier M, Meighen-Berger Micallef H, Pankova DV, Park N, Parker GK, Paudel EN, Paul L, P\u00e9rez de Los Heros C, Peters L, Peterson J, Philippen S, Pieloth D, Pieper S, Pittermann M, Pizzuto A, Plum M, Popovych Y, Porcelli A, Rodriguez Price Raab C, Raissi A, Rameez Rehman A, Reichherzer P, Reimann R, Renzi G, Resconi E, Reusch S, Rhode W, Richman M, Riedel B, Roberts EJ, Robertson S, Roellinghoff Cantu D, Safa I, Saffer J, Sanchez Herrera SE, Sandrock A, Sandroos J, Santander M, Sarkar S, Sarkar S, Satalecka M, Schaufel M, Schieler H, Schindler S, Schlunder P, Schmidt T, Schneider A, Schneider J, Schr\u00f6der FG, Schumacher L, Schwefer G, Sclafani S, Seckel Sharma J, CF, Turcati A, Turcotte R, Turley CF, Twagirayezu JP, Mentions: [1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/35179913/citedby/) S](https://profiles.ucsf.edu/simone.sacco), Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello KIR + CD8 + T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19. bioRxiv. 2021 Dec 25. Li J, Zaslavsky M, Su Y, Sikora MJ, van Unen V, Christophersen A, Chiou SH, Chen L, Li J, Ji X, Wilhelmy J, JR](https://profiles.ucsf.edu/jorge.oksenberg), Satpathy Mentions: - Specific hypomethylation programs underpin B cell activation in early multiple sclerosis. Proc Natl Acad Sci RD, Hawes PS, CK, O'Donovan BD, Tato CM, Lyden Sit R, Sowa GM, Sample HA, Zorn KC, Banerji D, Dominguez SR, Ng TFF, Marine RL, Lopez AS, Nix WA, Soldatos A, Gorman MP, Benson L, Messacar K, Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis. Neurology. 2021 10 19; Hauser SL, Kappos Hughes When We're There. Ann 28(4):654-664. Montalban X, Graves Julian L, Baker M, Schadrack J, Gossens C, Ganzetti M, Scotland A, Lipsmeier F, van Beek J, Bernasconi Haplotype Analyses of Classical HLA Genes in Families With Multiple Sclerosis Highlights the Role of HLA-DP Alleles in Disease Susceptibility. Front requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase M, A, Taylor B, MSBase Study Group, Giovannoni G, Kappos L, Hauser SL, Montalban X, Craveiro L, R, Model F, Overell J, Risk of requiring a walking aid after 6.5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis: Data from the OPERA I and OPERA II trials. Eur J Neurol. 2022 04; 29(4):1238-1242. Giovannoni G, neddylation as a novel therapeutic target in multiple sclerosis. Brain. 2021 03 03; 144(2):450-461. Kim J, Kogl E, L, Loudermilk R, Eggers EL, Singh S, Caillier SJ, Hauser SL, by B Cells in Multiple Sclerosis. N Engl J Med. 2021 multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA A, Herman A, Kappos L, Hauser S, Yamamoto Y, Wang Q, Model F, for multiple Hsu WY, Gomez R, A, Zhao C, Pearce JR, Jones cells traffic to the CNS in active multiple sclerosis. Sci Immunol. 2020 11 20; 5(53). Pr\u00f6bstel AK, Zhou X, Baumann Wischnewski S, Kutza M, Rojas OL, Sellrie K, Bischof A, Kim K, Ramesh A, [Dandekar R](https://profiles.ucsf.edu/ravi.dandekar), Greenfield AL, Schubert RD, Bisanz K, Landefeld J, Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MS. AJNR Am Role of B Cells in Multiple Sclerosis and Related Disorders. Ann Neurol. 2021 01; 89(1):13-23. Comi HP, Montalban X, S\u00f8rensen PS, Hohlfeld R, Hauser SL, Expert Panel of the 27th Annual Meeting of the European Charcot of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial. 2020 12; Arnold RT, Manfrini M, Overell J, Koendgen H, Sauter A, I, affect the heat shock response differently in human fibroblasts and iPSC-derived neurons. Dis Model Mech. 2020 10 12; Schuster Heuten Admard variants explain the association of European ancestry with multiple sclerosis risk in African-Americans. Sci Rep. 2020 10 09; 10(1):16902. Nakatsuka N, Patterson N, Patsopoulos A, Beecham AH, McCauley JL, S, of Atmospheric Muon Neutrino Data from the IceCube M, Ahrens M, Alispach C, Amin NM, Andeen K, Anderson T, Ansseau I, Anton G, Arg\u00fcelles C, Auffenberg J, Axani S, Bagherpour H, B](https://profiles.ucsf.edu/boris.bastian), Basu V, V, S, R, JJ, Becker KH, Becker Tjus J, BenZvi S, Berley B\u00f6ser O, B\u00f6ttcher J, Bourbeau S, Brostean-Kaiser J, Burgman A, Buscher J, Busse RS, Carver T, Chen C, Cheung E, Chirkin D, Choi S, Clark BA, Clark K, Classen L, Coleman A, Collin GH, Conrad JM, Coppin P, Correa P, Cowen DF, Cross R, Dave P, De Clercq C, DeLaunay JJ, Dembinski H, Deoskar K, De Ridder S, Desai A, Desiati P, de Vries KD, de Wasseige G, de With M, DeYoung T, Dharani S, Diaz A, D\u00edaz-V\u00e9lez JC, Dujmovic M, DuVernois MA, Dvorak PA, Fahey S, Fazely AR, Fedynitch A, Felde J, Fienberg AT, Filimonov K, Finley C, Fox D, Franckowiak A, Friedman E, Fritz A, Gaisser TK, Gallagher J, Ganster E, Garrappa S, Gerhardt L, Glauch T, Gl\u00fcsenkamp T, Goldschmidt A, Gonzalez JG, Grant D, Gr\u00e9goire T, Griffith Z, Griswold S, G\u00fcnder M, G\u00fcnd\u00fcz M, Haack C, Hallgren A, Halliday R, Halve L, Halzen F, Hanson K, Hardin J, Haungs A, Hauser S, Hebecker D, Heereman K, KD, Hoffmann R, Hoinka T, Hokanson-Fasig B, Hoshina K, Huang F, Huber M, Huber T, Hultqvist K, H\u00fcnnefeld M, Hussain R, In S, Iovine N, Ishihara A, Jansson M, Japaridze GS, Jeong M, Jones BJP, Jonske F, Joppe R, Kang D, Kang W, Kappes A, Kappesser D, Karg T, Karl M, Karle A, Katz U, Kauer M, Kellermann M, Kelley JL, Kheirandish A, Kim J, Kintscher T, Kiryluk J, Kittler Klein SR, Koirala F, QR, E, Mase K, Maunu R, McNally F, Meagher K, Medici M, Medina A, Meier M, Meighen-Berger S, Merz T, N, Pieloth Pieper Pinat A, Plum M, Popovych Y, A, Rodriguez Price Raissi A, Rameez M, Rauch Rea IC, Rehman A, Reimann R, Relethford B, Renschler M, Renzi G, Resconi E, Rhode W, Richman M, Riedel B, Robertson S, M, T, Ryckbosch D, Rysewyk Cantu D, Safa I, Sanchez Herrera SE, Sandrock A, Sandroos J, Santander M, Sarkar S, Sarkar M, Schaufel M, Schieler H, Schlunder P, Schmidt T, Schneider A, Schneider J, Schr\u00f6der FG, Schumacher L, Sclafani S, Seckel D, Seunarine Silva M, Smithers B, Snihur R, Soedingrekso J, Soldin D, Song GM, Spiering C, Stachurska J, Stamatikos M, Stanev M, Tung CF, Turcati A, R, CF, B, Unger Elorrieta Usner M, Vandenbroucke J, W, Eijk D, van Eijndhoven N, Vannerom D, van Santen J, Verpoest S, Vraeghe M, Walck C, Wallace in: [PubMed](https://www.ncbi.nlm.nih.gov/pubmed/33064514) Mentions: Fields: - Ataxin-1 regulates B cell function the severity of autoimmune experimental encephalomyelitis. Proc Natl Acad Sci U B, Caillier SJ, Shams H, Sclerosis Research: An Example of Bedside to Bench. JAMA. 2020 09 Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials. JAMA Arnold Bernasconi C, Model F, Koendgen H, Manfrini M, Belachew S, Hauser SL. PMID: 32511687; PMCID: [PMC7281382](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7281382). - A pathogenic and clonally expanded cell transcriptome in active multiple sclerosis. Proc Natl Acad Sci U S A. 2020 09 15; Ramesh A, Schubert Banerji D, University of California, San Francisco N Engl J Med. 2020 08 06; 383(6):546-557. Hauser SL, Bar-Or A, Cohen JA, Comi G, J, Coyle PK, AH, Selmaj K, Wiendl C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, H\u00e4ring DA, K, Merschhemke M, Kappos sclerosis. PLoS One. 2020; 15(8):e0235615. Caverzasi E, [Cordano C](https://profiles.ucsf.edu/christian.cordano), Zhu C, Bischof A, Kirkish G, Bennett DJ, Devereux M, OPERA studies open-label extension. Neurology. 2020 09 29; 95(13):e1854-e1867. Hauser SL, Kappos Arnold A Review. Am J Med. 2020 12; 133(12):1380-1390.e2. A Precision Medicine Tool for Patients With Multiple Sclerosis (the Open MS BioScreen): Human-Centered Design and Development. J Med Internet Res. 2020 07 06; 22(7):e15605. Schleimer E, Pearce J, Barnecut Klein A, [Block Hauser SL, [Baranzini [Oksenberg Brain MRI Predicts Worsening Multiple Sclerosis Disability over 5 Years in the SUMMIT Study. J Neuroimaging. 2020 03; 30(2):212-218. Bakshi R, Healy BC, Dupuy SL, Kirkish G, Khalid F, Gundel T, Asteggiano C, Yousuf F, Alexander A, Hauser cells in multiple sclerosis. Proc Natl Acad Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years. JAMA Neurol. 2019 Nov 01; Schubert RD, Hawes IA, Ramachandran PS, Ramesh CK, O'Donovan BD, Tato CM, Lyden HA, [Zorn KC](https://profiles.ucsf.edu/kelsey.zorn), Dominguez SR, Ng TFF, Marine RL, Lopez AS, Nix WA, Soldatos A, Gorman MP, Benson of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study. J Med Internet Res. 2019 Oct 08; 21(10):e16287. Midaglia L, Mulero P, Montalban X, Graves J, Hauser SL, Julian L, Baker M, Schadrack J, Gossens C, Scotland A, Lipsmeier F, van Length Is Associated with Disability Progression in Multiple Sclerosis. Ann Neurol. 2019 11; 86(5):671-682. Krysko KM, [Henry RG](https://profiles.ucsf.edu/roland.henry), Cree BAC, J, of California, San Francisco MS-EPIC Team, Caillier S, Santaniello A, Zhao C, Gomez R, Bevan C, [Smith DL](https://profiles.ucsf.edu/dana.smith), Normalization Strategies for Spinal Cord Total Cross-Sectional and Gray Matter Areas. J Neuroimaging. 2020 01; MRI efficacy of ocrelizumab in relapsing multiple sclerosis. Neurology. Hartung HP, Belachew S, Han J, Julian L, Sauter A, Napieralski J, matter lesion activity predicts clinical progression in primary progressive multiple sclerosis. Brain. 2019 09 01; 142(9):2787-2799. Elliott C, Belachew S, Wolinsky L, Barkhof F, Bernasconi C, Fecker J, Model F, of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study. J Med Internet Res. 2019 08 30; 21(8):e14863. Midaglia L, Mulero P, Montalban X, Graves J, Hauser SL, Julian L, Baker M, Schadrack J, Gossens C, Scotland A, Lipsmeier F, van experimental autoimmune encephalomyelitis. Nature. 2019 08; 572(7770):481-487. Saligrama N, Zhao F, Sikora MJ, Serratelli WS, Fernandes RA, Louis DM, Yao W, X, Idoyaga J, Mahajan VB, Steinmetz LM, Chien YH, Onset Progressive Multiple Sclerosis?\" Ann Neurol. 2019 09; alterations are associated with neural during J Autoimmun. 2019 07; 101:56-69. Didonna A, multiple sclerosis. Ann Neurol. 2019 05; 85(5):653-666. University motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson's disease. Proc Natl Acad U S Norman PJ, Creary cerebrospinal fluid B cells can resist treatment in multiple sclerosis. JCI Insight. 2019 03 21; 4(6). Greenfield AL, [Dandekar R](https://profiles.ucsf.edu/ravi.dandekar), Ramesh A, Eggers EL, Wu H, Laurent S, Harkin W, [Pierson NS](https://profiles.ucsf.edu/natalie.pierson), Weber MS, [Henry RG](https://profiles.ucsf.edu/roland.henry), Bischof with relapsing multiple sclerosis. J Neurol. 2019 May; 266(5):1182-1193. Turner patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies. K, Traboulsee A, Hauser SL, Julian L, K\u00f6ndgen H, Li C, Napieralski J, marker of disability worsening in the medium/long term in patients with expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions. Mult Scler. 2019 12; 25(14):1915-1925. Elliott L, Barkhof F, Bernasconi Body mass index, but not vitamin D status, is associated with brain volume change in MS. Neurology. 2018 of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial. Ann Neurol. 2018 10; Deol-Bhullar G, 25(11):1526-1534. [Bove Garcha P, Morrissey J, Dierkhising J, [Green AJ](https://profiles.ucsf.edu/ari.green), Raheja R, Glanz BI, Kivis\u00e4kk T, Jagodic M, 07; 84(1):51-63. Jia X, Madireddy A, Esposito F, Comi G, Stuve O, Zhou Y, B, Kilpatrick T, Stage. J Neuroophthalmol. 2018 during pregnancy: A systematic review, and a case series in MS and NMOSD. Neurol Neuroimmunol of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with Kappos L, Lublin F, Selmaj K, Traboulsee A, Belachew S, Bennett I, Buffels R, Garren H, Han J, Julian L, Napieralski J, signaling in peripheral blood mononuclear cells from multiple sclerosis patients. J Neuroinflammation. 2018 Mar 07; 15(1):72. Canto E, Isobe A magnetic resonance imaging marker of neurodegeneration throughout Harnessing electronic records to advance research on multiple sclerosis. Mult Scler. 2019 03; Santaniello A, Gomez R, [Lincoln R](https://profiles.ucsf.edu/robin.lincoln), Tang W, Chen T, Lee N, Villoslada an era. Ann Neurol. 2018 01; 83(1):13-26. Ovarian aging is associated with gray matter volume and disability in women with MS. Neurology. 2018 cells in treatment-naive multiple sclerosis patients. JCI Insight. 2017 11 16; 2(22). Eggers EL, Michel [Koth LL](https://profiles.ucsf.edu/laura.koth), Hauser SL, Dierkhising J, Vu N, Sriram S, Moses H, Bagnato F, Kaufmann JA, (ReBUILD): Arnow Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci U S Yoo Nelson CA, Kanner R, Bencosme Y, Lee YK, Hauser SL, Crabtree-Hartman E, Sand IK, Gacias M, Zhu Y, Casaccia Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple Mult Scler. F, Kinzig M, Stelzer C, Schindele D, Gauler T, Hauser S, Houtsma D, Roessler ways the VA can usher in the future of health care and research. 2017. Hauser SL, VanLeeuwen J-E. [View Publication](https://www.statnews.com/2017/05/29/veterans-va-health-care-research/). - Ocrelizumab in Primary Progressive and Sclerosis. N Engl J Med. 2017 04 Primary Progressive Multiple Sclerosis. N Engl J Med. 2017 01 19; 376(3):209-220. Montalban X, Hauser SL, Kappos L, DL, Bar-Or A, Comi G, de Seze J, Giovannoni N Engl J Med. 2017 19; 376(3):221-234. Hauser SL, Bar-Or Comi S, Chin P, Mairon N, Garren H, Kappos L, OPERA I and OPERA secondary progressive MS after long-term rituximab therapy - a case report. Long-term evolution of multiple sclerosis disability in the treatment era. Ann Neurol. 2016 10; 80(4):499-510. University of California, San Panara V, loci and disease severity in 7,125 individuals from 10 studies. Neurol Genet. 2016 Aug; 2(4):e87. George MF, Harbo HF, Celius Bos A, Shen L, Bernstein A, Alfredsson L, Hillert J, Olsson T, Patsopoulos NA, Oturai MA, Martinelli Boneschi F, Sorosina M, van der Mei I, Taylor Y, of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis. JAMA Neurol. 2016 07 01; for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma. Oncogene. 2017 01 05; 36(1):110-121. Iltzsche S, Pattschull G, Francke S, Wolter P, Hauser S, Murphy DJ, Garcia P, 01; Shinohara RT, Stern A, Comabella JC](https://profiles.ucsf.edu/jason.crane), D'Alfonso Fontaine B, Gaetano L, Goris BMJ, Villoslada P, Wattjes MP, Weiner H, Wuerfel J, Zimmer C, Zipp F, International Multiple Sclerosis Genetics Consortium. Electronic studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis. Int J Epidemiol. P, [Cozen W](https://profiles.icts.uci.edu/wendy.cozen), Himmelstein DS, Madireddy L, Din L, van den Berg A, Matsushita T, Glaser SL, Mor\u00e9 JM, Smedby KE, [Baranzini SE](https://profiles.ucsf.edu/sergio.baranzini), Gourraud Nieters A, Hauser Cocco P, Maynadi\u00e9 M, Foretov\u00e1 L, Staines A, Delahaye-Sourdeix M, Li D, Bhatia S, risk affects Mol Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat Genet. 2015 Oct; 47(10):1107-1113. Moutsianas L, Jostins L, Beecham DK, Ban M, Shah TS, Patsopoulos NA, Alfredsson L, Anderson CA, Attfield KE, [Baranzini SE](https://profiles.ucsf.edu/sergio.baranzini), Barrett J, Binder TMC, Booth D, Celius EG, Cotsapas C, D'Alfonso S, Dendrou CA, Donnelly Fontaine B, Fugger L, Goris A, Gourraud PA, Graetz J, IBD Consortium Leslie Lill J, Zipp F, Haines JL, Pericak-Vance MA, Spencer CCA, Stewart G, Hafler DA, Ivinson AJ, Harbo HF, Spinal Cord Gray Matter Atrophy and Disability in Multiple JAMA Neurol. sclerosis risk among Ashkenazi Jews. BMC Med Genet. 2015 Jul 28; 16:55. Khankhanian Liz\u00e9e Rofo. 2015 Jul; 187(7):577-83. Pieper CC, Fischer S, Strunk H, Meyer C, Thomas D, Willinek WA, Hauser S, Nadal J, Schild study of multiple sclerosis risk in African Americans. Brain. 2015 Jun; 138(Pt 6):1518-30. Isobe PA, JL, Beecham AH, International Multiple Sclerosis Genetics Consortium, Piccio L, Herbert J, Khan O, Cohen J, Stone L, Santaniello A, Cree BA, Onengut-Gumuscu S, Rich SS, gender and normalization covariates for spinal cord gray matter and total cross-sectional areas at cervical and thoracic levels: A 2D phase sensitive R, Panara associations brain cortical thickness in multiple sclerosis. Genes Brain Behav. 2015 Feb; 14(2):217-27. Matsushita T, Madireddy L, Sprenger Naegelin extraordinary evidence still needed. JAMA. 2015 Jan MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat Genet. 2015 Feb; P, Boucher Mallon L, Huang H, Ripke ES, Annese V, Hauser SL, [Oksenberg JR](https://profiles.ucsf.edu/jorge.oksenberg), Thomsen I, Leslie S, International Inflammatory Bowel Disease Genetics Consortium, Australia and New Zealand IBDGC, Belgium IBD Genetics Consortium, Italian Group for IBD Genetic Consortium, NIDDK Inflammatory Bowel Disease Genetics Consortium, United Kingdom IBDGC, Wellcome Trust Case Control Consortium, Quebec IBD Genetics Consortium, Daly MJ, Van Steen to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times. J Magn Reson Imaging. 2015 Sep; 42(3):698-708. [Papinutto N](https://profiles.ucsf.edu/nico.papinutto), V, Caverzasi S, Johnson KJ, Zhu AH, Stern WA, G, | beating MS: a story of B cells, with twists and turns. Mult Scler. 2015 multiple sclerosis BioScreen. Ann Neurol. cord matter atrophy correlates with multiple sclerosis disability. Ann Neurol. form an active immune axis between CNS and periphery in multiple sclerosis. Sci Transl Med. 2014 Aug 06; 6(248):248ra106. Palanichamy screening platform for therapeutics in multiple sclerosis. Nat Med. 2014 Aug; 20(8):954-960. Mei F, [Fancy SPJ](https://profiles.ucsf.edu/steve.fancy), Shen YA, Niu J, Zhao C, Presley B, Miao E, Lee S, Mayoral SR, Redmond SA, Etxeberria A, Xiao L, Franklin One. 2014; of disease progression in multiple sclerosis. JAMA Jul 01; Oh J, Cree BA, M, Hauser SL, CD20-expressing T cells in multiple sclerosis patients. J Immunol. 2014 Jul 15; 193(2):580-586. Palanichamy A, Jahn S, in neuroscience research. Ann Neurol. 2014 manifestations in European SLE. Genes Immun. 2014 Apr; 15(4):210-7. Morris DL, Fernando MM, Alarc\u00f3n-Riquelme ME, Barcellos RR, Pons-Estel BA, Gregersen PK, Harley JB, Hauser SL, peripheral B-cell responses. Ann Neurol. 2014 Feb; 75(2):266-76. Bankoti J, Apeltsin L, Hauser bands and age at onset correlate with genetic risk score in multiple sclerosis. May; 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013 Nov; 45(11):1353-60. International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, Fontaine B, Hemmer B, Martin C, F, Taylor B, Harbo HF, JR](https://profiles.ucsf.edu/jorge.oksenberg), Hintzen R, Barcellos LF, Wellcome Trust Case (WTCCC2), International IBD Genetics Consortium (IIBDGC), Agliardi C, Alfredsson L, Alizadeh M, Anderson C, Andrews S\u00f8ndergaard HB, Baker A, Band G, [Baranzini SE](https://profiles.ucsf.edu/sergio.baranzini), Barizzone Bellenguez C, Bergamaschi Berthele A, Biberacher IL, Brambilla P, Broadley S, Cree BA, Cusi D, Damotte V, Defer G, Delgado SR, Deloukas P, di Sapio A, Dilthey AT, Donnelly P, Dubois B, Duddy M, Edkins S, Elovaara I, Esposito F, Evangelou N, IY, Galimberti D, Gieger V, Guaschino C, Hadjixenofontos A, Hakonarson H, Halfpenny C, Hall G, Hall P, Hamsten A, Harley J, Harrower T, Hawkins C, Hellenthal G, Hillier C, Hobart J, Hoshi M, Hunt SE, Jagodic M, Jelcic I, Jochim A, Kendall B, Kermode A, Kilpatrick T, Koivisto K, Konidari I, Korn T, Kronsbein H, Langford C, Larsson M, Lathrop M, Lebrun-Frenay C, Lechner-Scott J, Lee MH, Leone MA, Lepp\u00e4 V, Liberatore G, Lie BA, Lill CM, Mazibrada G, McCabe C, Mero IL, Mescheriakova J, Moutsianas L, Myhr KM, Nagels G, Nicholas R, Nilsson P, Piehl F, Pirinen M, Price SE, Quach H, Reunanen M, Robberecht W, Robertson NP, Rodegher M, D, Salvetti M, Schnetz-Boutaud NC, Sellebjerg F, Selter RC, Schaefer C, Shaunak S, Shen L, Shields S, Siffrin V, Slee M, Sorensen PS, Sorosina M, Sospedra E, V, J, A, Haines JL, Pericak-Vance Ivinson AJ, Stewart G, Hafler D, Hauser of Annals: Therapeutic prospects. Ann Neurol. 2013 Sep; Neurol. Genes Immun. 2013 Oct; 14(7):434-440. Isobe N, Damotte I, Compston a critical role in the activation of encephalitogenic T cells in CNS autoimmunity. J Exp Casazza S, of sequestration. Ann Neurol. 2013 Jul; 74(1):A5-6. variants with multiple sclerosis. Neurology. 2013 S, Pando MJ, Piccio L, Cross AH, De Jager Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls. Hum Mol Genet. 2013 Oct 15; 22(20):4194-205. Nickles D, Khankhanian L, Caillier SJ, Santaniello an \"M&M\" of endovascular therapies for stroke. Ann association between mutant alleles of the CYP27B1 gene and multiple sclerosis. Ann Neurol. 2013 Mar; 73(3):430-2. study of brain lesion distribution in multiple sclerosis. Brain. 2013 Apr; Mult Scler. 2013 Jul; 19(8):1014-21. McElroy JP, Caillier SJ, Gourraud medical records and the academic neurologist: when carrots turn into sticks. Ann Neurol. 2012 cell across the blood-brain barrier in multiple sclerosis. J Clin Invest. PA, Schwartzburg A, Huerta G, Telman D, Sundar PD, T, associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans. Am J Hum Genet. 2012 Nov 02; 91(5):778-93. Morris DL, Taylor KE, Fernando Nititham J, Alarc\u00f3n-Riquelme ME, Barcellos LF, Behrens TW, RR, Pons-Estel BA, Gregersen PK, Harley JB, Hauser SL, Hom G, International MHC and Autoimmunity Genetics Network, Langefeld Fields: - In depth comparison of an individual's DNA and its lymphoblastoid cell line using on blood sports. Ann Neurol. 2012 [Humans] - Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol. Ann Neurol. Rev. of structural variation at autism spectrum disorder candidate loci. Mol Autism. 2012 Apr 02; 3:2. Hauser 2012 Mar; [Humans] - care for problems must address waste. Ann Neurol. 2012 Feb; 71(2):A5-6. [Humans] - Color vision is strongly associated with retinal thinning in multiple sclerosis. Mult Scler. 2012 Jul; 18(7):991-9. Villoslada Neurol. 2011 Dec; 70(6):897-912. Patsopoulos NA, Bayer Pharma MS Genetics Working Group, Steering Committees of Studies Evaluating IFN\u00df-1b and a CCR1-Antagonist, ANZgene Consortium, GeneMSA, International Multiple Sclerosis Genetics Consortium, Esposito F, Reischl J, Lehr S, Bauer D, Heubach J, Sandbrink R, Pohl C, G, Kappos L, Miller D, CH, Freedman MS, Hartung HP, G, Cook S, Filippi Hillert J, S, MA, Browning BL, Browning SR, Butzkueven WM, Chapman SJ, Griffiths L, Kermode AG, Kilpatrick TJ, Lechner-Scott J, Marriott M, Mason D, Moscato P, Heard RN, Pender MP, Perreau E, Wiley J, Matthews P, Boneschi FM, Compston A, Haines J, Hauser SL, by chronic lymphocyte ablation. Proc Natl U GR, [Oksenberg JR](https://profiles.ucsf.edu/jorge.oksenberg), Hauser SL, DR, Rajpal weighs in. Ann Neurol. 2011 Nov; trial. 2011 Nov 19; 378(9805):1779-87. Kappos Li D, Calabresi PA, O'Connor P, Bar-Or A, Barkhof F, Yin M, Leppert D, Glanzman cell lung cancer: randomized phase III trial Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011 Aug 10; 476(7359):214-9. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela Bellenguez C, Fontaine M, Hemmer B, Gwilliam R, Zipp F, Jayakumar A, Martin R, Leslie S, Hawkins S, Giannoulatou E, D'alfonso S, Blackburn H, Martinelli Boneschi M, Comabella M, Hammond N, Kockum I, McCann OT, Ban M, Whittaker P, Kemppinen A, Weston P, Hawkins C, Widaa S, Zajicek S, Robertson R, Alfredsson Baker A, Baker K, [Baranzini SE](https://profiles.ucsf.edu/sergio.baranzini), Bergamaschi L, Bergamaschi R, Bernstein Bradfield JP, Brassat D, Broadley SA, Buck D, M, Cournu-Rebeix I, Cox MB, [Cozen W](https://profiles.icts.uci.edu/wendy.cozen), Cree BA, Cross AH, Cusi D, Daly MJ, Davis E, de Bakker PI, Debouverie M, D'hooghe MB, Dixon K, Dobosi R, Dubois B, Ellinghaus D, Elovaara I, Esposito F, Fontenille C, Foote S, Franke A, Galimberti D, Ghezzi A, Glessner J, Gomez R, Gout O, Graham C, Grant SF, Guerini FR, Hakonarson H, Hall P, Hamsten A, Hartung RN, Heath S, Hobart J, Hoshi M, Infante-Duarte W, [Islam T](https://profiles.sc-ctsi.org/khandaker.islam), Jagodic M, Kabesch M, Kermode AG, Kilpatrick J, Lorentzen AR, Lupoli S, [Macciardi F](https://profiles.icts.uci.edu/fabio.macciardi), Mack T, Marriott Mentch E, Blackwell JM, Tienari P, Bramon E, Tourbah A, Brown N, Corvin A, Vickery J, P, AC, Zhang H, Wood NW, Deloukas P, Langford C, Duncanson A, [Oksenberg MA, JL, De Jager PL, Peltonen L, Stewart GJ, Hafler DA, Hauser multiple sclerosis: updated recommendations for patient selection and monitoring. Lancet Neurol. 2011 Aug; 10(8):745-58. Kappos L, Bates D, Edan Grigoriadis N, Hartung E, Hillert J, Hohlfeld R, Kremenchutzky M, Lyon-Caen A, Pozzilli C, Ravnborg M, Saida T, Sindic C, Vass K, Clifford DB, Hauser S, Major EO, O'Connor PW, Weiner HL, Clanet M, Gold R, Hirsch HH, Rad\u00fc an appeal for research. Ann Neurol. 2011 HLA locus in Japanese multiple sclerosis patients. Genes Immun. 2011 Oct; 12(7):523-30. McElroy JP, Isobe Kohriyama role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex. Hum Beecham PL, International Multiple Sclerosis Genetics Consortium, Ivinson AJ, Compston A, Hafler multiple sclerosis. Neurology. 2011 May 24; 76(21):1824-30. matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler. [Humans] - Enhancing ties between academia and industry to improve health. Nat Med. 2011 Apr; 17(4):434-6. Johnston 2011 Apr; 69(4):A9-A10. 2011 Mar; 69(3):A9-10. interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility. Genes Immun. Polman CH, Hauser SL, [Oksenberg J](https://profiles.ucsf.edu/jorge.oksenberg), Haines JL, cumulative genetic risk for multiple sclerosis from genome-wide association data. Genome Med. 2011 Jan 18; 3(1):3. Wang JH, Pappas D, De Jager de Bakker PI, Kappos L, Polman CH, Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Chibnik LB, Hafler multiple sclerosis genetic risk variants in multiple and single case families. Ann Neurol. 2011 Jan; 69(1):65-74. Gourraud PA, McElroy JP, odorant receptors family 13 and the mhc loci influence mate selection in a multiple sclerosis dataset. BMC Genomics. 2010 scalpel. Ann (1924-2010) the founding of the Annals of Neurology. Ann Neurol. 2010 Sep; variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain. 2010 Sep; 133(9):2603-11. [Baranzini SE](https://profiles.ucsf.edu/sergio.baranzini), Srinivasan R, Khankhanian for in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals. Hum Mol Genet. 2010 Nov 01; 19(21):4286-95. Briggs SJ, epidemiology. Ann Neurol. 2010 Aug; 68(2):A8-10. old drug. Ann Neurol. 2010 Jul; 68(1):A8-9. Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01. 1 (MMEL1) is associated with multiple sclerosis. Genes Immun. 2010 Dec; 11(8):660-4. Ban M, McCauley JL, Zuvich S, Guerini FR, J, Variation within DNA repair pathway genes and risk of multiple sclerosis. Am J Epidemiol. 2010 Jul 15; 172(2):217-24. support for association between the KIF1B rs10492972[C] variant and multiple sclerosis. Nat Genet. 2010 Jun; 42(6):469-70; author reply 470-1. International Multiple Sclerosis Genetics Consortium (IMSGC), Booth DR, Heard RN, Stewart GJ, Cox M, Scott RJ, Lechner-Scott J, Goris Dobosi Dubois J, Kockum I, Olsson T, Hillert J, Ban M, Baker A, Kemppinen A, Sawcer S, Compston A, Robertson NP, the association of MHC with multiple sclerosis in African Americans. Hum Mol Genet. 2010 Aug 01; 19(15):3080-8. McElroy JP, Gregersen PK, Herbert J, Khan OA, Freudenberg neurology. Ann Neurol. 2010 of monozygotic twins discordant for sclerosis. Nature. 2010 Apr 29; 464(7293):1351-6. [Baranzini SE](https://profiles.ucsf.edu/sergio.baranzini), Mudge J, van Velkinburgh JC, Khankhanian P, Khrebtukova I, Miller NA, Zhang L, Farmer AD, Bell CJ, Kim RW, May GD, Woodward JE, Caillier Schilkey Wu TD, sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain. 2010 Jun; 133(Pt 6):1591-601. [Green AJ](https://profiles.ucsf.edu/ari.green), Neurol. 2010 Apr; 67(4):452-61. Bar-Or Fawaz A, Ghorayeb C, Calabresi PA, [Waubant E](https://profiles.ucsf.edu/emmanuelle.waubant), Ann Neurol. 2010 Apr; 67(4):A5-8. Hauser in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis. Hum Mol Genet. 2010 MA, Haines JL, association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet. 2010 game: can we accelerate training for clinician-scientists? Ann Neurol. variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Genetics Consortium, Aubin C, Cross AH, Piccio L, Aggarwal NT, Evans D, Hafler DA, Compston patterns of population structure and admixture in West Africans and African Americans. Proc Natl Acad Sci U S A. 2010 Jan Bryc K, Auton A, Nelson MR, [Oksenberg Williams S, Froment A, trainees the clinical neurosciences: still a shallow pool. Ann Neurol. 2009 Dec; task impossible: set the agenda for neurological comparative effectiveness research. Ann Neurol. 2009 Nov; 66(5):A4-6. African Americans. Genes Immun. 2010 Jun; 11(4):343-50. Johnson BA, Wang J, Taylor EM, Caillier SJ, Herbert J, Khan OA, Cross AH, De MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci U S A. 2009 and P, Vyse TJ, Hammarstr\u00f6m L, Fernando MM, Green T, De Jager PL, Foisy S, Wang J, de Bakker PI, Leslie S, McVean G, Padyukov L, Alfredsson L, sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol. 2009 Oct; K, O'Connor P, Freedman MS, Calabresi PA, Antel J, Simon J, Hauser S, [Waubant E](https://profiles.ucsf.edu/emmanuelle.waubant), Vollmer T, Panitch H, Zhang J, Chin of natalizumab. Ann Neurol. 2009 innocent. Ann Neurol. 2009 Aug; association to chromosome 1q43 in mental illness. Ann Neurol. 2009 Jul; identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet. 2009 Jul; 41(7):776-82. De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Tran D, Aubin C, MA, Haines Polman C, of life in multiple sclerosis is associated with lesion burden and brain volume measures. Neurology. 2009 BA, Qualley P, Lincoln R, George MF, Gomez R, Hauser SL, Okuda DT, Ann Neurol. 2009 May; 65(5):A7-8. analysis identifies TYK2 as a multiple sclerosis susceptibility factor. Eur J Hum Genet. 2009 Oct; 17(10):1309-13. Ban M, Goris A, Lorentzen AR, Baker A, Mihalova T, Ingram G, Booth DR, Heard RN, Stewart E, Dubois B, Harbo HF, Celius Spurkland Strange R, Hawkins C, NP, Dudbridge F, Wason J, De genome-wide association studies in multiple sclerosis. Genet. 2009 01; L, GeneMSA Consortium, CH, Matthews like these... Ann Neurol. 2009 Mar; in multiple sclerosis. Proc Natl Acad Sci U A. 2009 Mar 31; 106(13):5264-9. De Jager PL, Baecher-Allan C, J, Yelensky R, Price A, Leppa V, Patterson N, de Bakker PI, Tran D, Aubin C, Pobywajlo S, Rossin E, Hu CW, Choy E, Rioux JD, Pericak-Vance MA, Ivinson A, Booth DR, GJ, Peltonen L, Dubois B, Haines JL, Weiner HL, Compston A, Hauser SL, Sclerosis Phenotypes by African Ancestry at HLA. Arch Neurol. 2009 Feb; 66(2):226-33. [Cree BA](https://profiles.ucsf.edu/bruce.cree), Reich DE, Jager PL, Nakashima I, Takahashi T, Bar-Or neurosciences. Ann Neurol. 2009 Feb; 65(2):A6-8. heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet. 2009 Jan; 5(1):e1000322. Maier LM, Lowe CE, Cooper J, Downes K, Anderson DE, Severson C, Clark PM, Healy B, Walker N, Aubin C, [Oksenberg JR](https://profiles.ucsf.edu/jorge.oksenberg), Hauser SL, Compston A, Sawcer S, International Multiple Sclerosis Genetics Consortium, De Jager PL, Wicker LS, Todd JA, radiologically isolated syndrome. new administration: what sort of change to believe in? Ann Neurol. 2008 Dec; genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain. Lincoln R, Gomez R, Caillier S, George M, Wang J, Nelson SJ, Cree BA, Hauser SL, and clinical phenotype in multiple sclerosis. Hum Mol Genet. 2009 Feb 15; [Baranzini Gass review National Institutes of Health: small steps forward. Ann Neurol. 2008 Nov; sclerosis. N Engl J Med. 2008 Oct 23; and HLA-DRB5 genes in multiple sclerosis. J Immunol. 2008 Oct 15; Caillier science: a new wrinkle on academic ties with industry. Ann Neurol. 2008 Oct; 64(4):A13-5. Sample, POPRES: a resource for population, disease, and pharmacological genetics research. Am J Hum Genet. 2008 Sep; 83(3):347-58. Nelson MR, Bryc JS, Chambers JC, Jones B, Mooser V, Bustamante CD, Roses AD, Burns DK, Ehm MG, of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event. Proc Natl Acad Sci U S A. for healthcare. Ann Neurol. 2008 Aug; 64(2):A8-9. agenda. Ann Neurol. 2008 Jul; 64(1):A11-2. 2A (NOS2A) and risk 2008 Jun; 63(6):A11-2. - Electronic medical records: does it take a village or a thousand points of light? Ann Neurol. 2008 Apr; electromagnetic hypersensitive patients: results of a case-control study. Psychol Med. 2008 Dec; Landgrebe M, Frick Hauser Mar; 63(3):A15-6. sclerosis. N Engl J Med. 2008 Feb 14; 358(7):676-88. Hauser SL, [Waubant Arnold N, 2007 Dec; multiple sclerosis. Hum Nov; 68(11):934-7. Begovich AB, Chang M, Caillier SJ, the ANA. Ann Neurol. 2007 Sep; 62(3):A11. in sclerosis identified by a genomewide study. N Engl J Med. 2007 Aug 30; 357(9):851-62. International Multiple Sclerosis Genetics Consortium, Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, de Bakker PI, Gabriel SB, alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet. 2007 Sep; 39(9):1083-91. Gregory SG, Schmidt S, Seth P, [Oksenberg JR](https://profiles.ucsf.edu/jorge.oksenberg), Hart J, Prokop Garcia-Blanco MA, Pericak-Vance MA, Haines JL, Multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurol. 2007 May; 6(5):431-41. Kappos L, Bates D, Hartung HP, Havrdova E, Miller D, Polman CH, Ravnborg M, Hauser SL, Rudick RA, Weiner HL, O'Connor PW, King J, Radue EW, engines for progress? Ann Neurol. 2007 May; versus review: a randomized lures of industry. Ann Neurol. 2007 histocompatibility for multiple sclerosis. Ann Neurol. 2007 Mar; 61(3):228-36. Yeo TW, De Jager Barcellos LF, Walton A, Goris A, Fenoglio C, Ban M, Taylor CJ, Goodman RS, Walsh E, Wolfish CS, Horton R, Traherne J, Beck S, Trowsdale J, Caillier SJ, Ivinson AJ, Green T, Pobywajlo Haines JL, Daly and crying? Ann Neurol. 2007 multiple sclerosis. Neurology. 2007 Jan 30; Vecsei L, Stewart G, Dubois B, Bellman-Strobl J, Leone M, Andersen O, Bencsik K, Booth D, Celius EG, Harbo HF, Hauser research, without grade inflation. Ann Neurol. 2006 Dec; from bench to bedside (if your health plan concurs). Ann Neurol. 2006 Nov; 60(5):10A-11A. of diseases in families with a high-risk for multiple sclerosis: a descriptive study. inflammation, and neurodegeneration. Neuron. multiple sclerosis: a multifactorial approach reveals associations with inflammatory genes. Motsinger LL, Barcellos LF, Pericak-Vance MA, Schmidt S, Gregory S, SL, the clinician-scientist: report of the ANA long range planning committee. Ann Neurol. 2006 Sep; 60(3):278-85. cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). Br J Cancer. 2006 Aug 21; transmit MS more often to their children vs women: the Carter effect. Neurology. 2006 and clinical research: what is the most appropriate weighting in a public investment portfolio? Ann Neurol. 2006 Jul; the herpes virus entry mediator-B gene (PVRL2) with the severity of multiple sclerosis. Genes Immun. 2006 Jul; 7(5):384-92. Schmidt S, Pericak-Vance MA, Sawcer S, Barcellos LF, Hart J, Sims J, Prokop AM, van der Walt J, DeLoa C, Lincoln RR, [Oksenberg JR](https://profiles.ucsf.edu/jorge.oksenberg), Compston A, Hauser SL, Haines JL, Gregory SG, sclerosis susceptibility and disease severity: some answers. Neurology. 2006 May 09; Schmidt Schmidt R, Hillert J, Masterman T, Hogh P, Niino M, Kikuchi S, Maciel P, Santos M, Rio ME, Kwiecinski H, B, a hazy lens. Ann Neurol. for therapy. Ann Neurol. 2006 May; 59(5):731-2. gene-gene interactions associated with multiple sclerosis susceptibility in African Americans. Genes Immun. 2006 Jun; 7(4):310-5. Brassat LL, Cree BA, Barcellos LF, Pericak-Vance MA, Schmidt S, Gregory S, Hauser elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental candidate regions for multiple sclerosis: strong evidence of linkage to SL, Barcellos LF, splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15. Hum for disease progression in multiple sclerosis: evidence, experience, and future expectations. Arch Neurol. 2005 Oct; Frohman R, Sorensen PS, Phillips JT, B, Hawker K, Hartung HP, Steinman L, [Zamvil S](https://profiles.ucsf.edu/scott.zamvil), Cree BA, Hauser S, in complex disorders: Integration of expression and genomic scans for multiple sclerosis. J Neuroimmunol. 2005 Oct; a candidate locus for multiple sclerosis susceptibility. Nat Genet. 2005 Oct; 37(10):1113-8. Reich D, Patterson N, De G, Kelly MA, Francis DA, Ardlie K, Khan O, Cree BA, Hauser SL, of progression in multiple sclerosis: evidence and new hypotheses for future directions. Arch Neurol. 2005 Sep; 62(9):1345-56. Frohman EM, Filippi C, J, Karandikar N, B, Keyser J, Hartung H, Steinman stage-specific biomarkers in multiple sclerosis. Menge T, sclerosis. Am J Hum Genet. 2005 Sep; 77(3):454-67. Sawcer S, Ban M, A, Kirby A, Daly MJ, Jager Walsh Lander ES, Rioux JD, Hafler DA, Ivinson A, Rimmler J, Gregory Pericak-Vance MA, Akesson E, Hillert J, Datta HF, Spurkland A, Myhr KM, Laaksonen M, Sicily. Neurology. 2005 tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am Hum Genet. 2005 Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology. 2004 Dec 14; 63(11):2039-45. Cree BA, Khan O, JA, Marrie RA, [Glidden sclerosis. J Neurol Sci. 2005 Feb 15; 75(6):1070-8. I, Neurology. 2004 Sep 28; disease phenotype and antibody effector Eur J 2004 De Jager PL, Gabriel S, Hafler DA, Ivinson AJ, Lander ES, Rioux JD, Walsh E, Gregory SG, Schmidt S, Pericak-Vance MA, locus on chromosome 17q11 Schmidt S, Grams SE, Walker Steiner LL, Cree BA, Stillman A, [Lincoln RR](https://profiles.ucsf.edu/robin.lincoln), disease genes. Am J Hum Genet. 2004 May; 74(5):979-1000. Patterson N, susceptibility to the HLA-DR locus in African Americans. Am L, [Goodin D](https://profiles.ucsf.edu/douglas.goodin), Erlich HA, Schmidt S, Thomson G, Reich DE, MA, Haines JL, proposed regions of linkage in multiple sclerosis: an American and French Duhamel Haines JL, Pericak-Vance M, Hauser SL, [Oksenberg JR](https://profiles.ucsf.edu/jorge.oksenberg), May 24; 361(9371):1824; author reply 1824-5. Rudick RA, Cookfair DL, in multiple sclerosis. Genes Immun. 2003 Mar; 4(2):147-52. effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet. 2003 Mar; 72(3):710-6. Barcellos D, A, Pericak-Vance MA, Haines JL, Hauser SL, Mol Genet. 2002 Sep 15; 11(19):2251-6. Haines JL, Bradford Y, Reed AD, Neumeister E, Pericak-Vance HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta. J Neuroimmunol. 2002 Sep; to myelin oligodendrocyte glycoprotein: a multiple sclerosis beet chlorosis virus (BChV). Arch Virol. 2002 Apr; 147(4):745-62. polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis. Am J Hum Genet. 2002 Mar; ER, Vance JM, [Oksenberg JR](https://profiles.ucsf.edu/jorge.oksenberg), Hauser SL, Pericak-Vance MA, encoding the MHC sclerosis. Neurogenetics. 2001 Oct; 3(4):195-201. Pericak-Vance jacchus. not associated with the development of multiple sclerosis in U.S. patients. Nat Genet. 2001 Sep; 29(1):23-4. - Treatment of is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Arch Neurol. 2001 Jul; the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibility. J Neuroimmunol. 01; 116(1):116-24. Green AJ, Barcellos Lincoln Pericak-Vance MA, Haines JL, Hauser SL, [Oksenberg of the response to myelin basic protein in a non human primate model for multiple sclerosis. Eur J Immunol. 2001 Feb; 31(2):474-9. Uccelli receptor gamma is linked to ligand-dependent activation. J Biol Chem. 2000 Jun 16; 275(24):18527-33. Hauser S, Adelmant G, P, factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J Exp Med. 2000 May 15; 191(10):1799-806. Villoslada P, Hauser SL, Bartke I, Unger J, Heald N, Rosenberg D, and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group. Neurology. 2000 May 09; 54(9):1859-61. Hauser SL, [Oksenberg JR](https://profiles.ucsf.edu/jorge.oksenberg), Lincoln R, Garovoy J, Beck RW, Cole SR, Moke PS, Kip KE, and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group. proliferator-activated receptor gamma inhibits adipocyte differentiation. J Biol Chem. 2000 Jan 21; 275(3):1873-7. Wright HM, Clish CB, T, 99(1):36-43. Diaz-Villoslada P, Pham-Dinh D, Boesplug-Tanguy O, Carsique R, Fitoussi and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann Neurol. 1999 domain of PPARgamma. EMBO J. 1999 Jul 01; 18(13):3676-87. Castillo G, Brun RP, Rosenfield JK, Hauser S, Park CW, Troy AE, associated with myelin damage in multiple sclerosis. Nat Med. 1999 Feb; 5(2):170-5. CP, is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain. 1998 Dec; 121 ( Pt 12):2327-34. Leppert D, Ford J, Stabler G, Grygar C, Lienert C, Huber S, Miller KM, neonatal morbidity and mortality. Aust N Z J Med. 1998 familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum Mol Genet. 1998 Aug; 7(8):1229-34. Martin [Oksenberg JR](https://profiles.ucsf.edu/jorge.oksenberg), Lincoln R, Zhang DY, DR, Gatto acidosis: clinical and biochemical findings in eleven subjects. Clin Chem. 1998 Jul; 44(7):1497-503. complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes. 1998 Apr; 47(4):583-91. Kwon G, Corbett JA, Hauser S, Hill JR, expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid. J Clin Invest. 1997 Ghanbari by vaccination with recombinant vaccinia virus encoding for myelin protein. J Neuroimmunol. 79(2):119-28. and heterozygotes (carriers) by measurement of deficient 7-reductase in fibroblasts. Metabolism. 1997 Jul; 46(7):844-50. Shefer S, Salen G, Honda A, Batta A, Hauser S, Tint GS, Honda M, Chen T, sclerosis in Callithrix jacchus lymphocytes in chronic encephalitis of Rasmussen. J Immunol. 1997 chain repertoire in the New World monkey Callithrix jacchus. of immune deviation therapy in a nonhuman primate. Science. 1996 Dec 20; 274(5295):2054-7. Genain and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Ann Neurol. 1996 Dec; 40(6):846-52. Leppert Biased expression of T cell receptor genes characterizes activated T cells in multiple sclerosis cerebrospinal fluid. J Neurosci Res. 1996 Sep 15; 45(6):829-37. Usuku K, Joshi N, CJ, haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion. Hum Immunol. 1996 Garcia-Merino genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet. 1996 13(4):469-71. Haines Roses Seboun E, Fitoussi F, Gyapay G, Weissenbach J, SL, Goodkin DE, R, of interferon beta-1b in MS: results of an open specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol. 1996 Jan 01; 156(1):160-7. Xia M, Leppert D, Hauser What to tell patients with their first attack of multiple sclerosis. Eur Neurol. 1996; 36(4):183-90. sclerosis-like lesions in a nonhuman primate. J Clin 96(6):2966-74. cells by eicosanoids. FASEB J. 1995 Nov; 9(14):1473-81. Leppert D, polymorphisms and genetic susceptibility to demyelinating diseases. Ann N Y Acad Sci. 1995 Jul in vitro. J cAMP-specific phosphodiesterase inhibitor. Genain CP, Roberts T, Davis RL, Nguyen MH, Uccelli A, Faulds D, Li Y, induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. Neurol. in cerebrospinal fluid of multiple sclerosis patients. Ann Neurol. 1995 Jan; 37(1):63-6. Rozniecki JJ, Hauser SL, Seibert Zhang Y, Leahy K, Hauser S, Gierse J, Koboldt C, Anderson G, Bremer M, Gregory S, Suppl. 1995; 46:41-50. Seibert K, Masferrer J, Zhang Y, Gregory S, Olson G, Hauser S, Leahy K, Perkins W, Isakson Y Acad Sci. 1994 Nov 15; 744:181-3. Isakson P, Hauser S, Zhang Y, Leahy in: [PubMed](https://www.ncbi.nlm.nih.gov/pubmed/21559636) Mentions: Fields: - West 161(3):331-4. healthy circulating autoreactive T cells mediate autoimmune disease. J Clin Invest. 1994 Sep; 94(3):1339-45. Genain CP, Lee-Parritz D, Nguyen Massacesi Ferrante R, Hoffman K, basic protein in familial multiple sclerosis: diversity of fine specificity, restricting elements, and T-cell receptor usage. Ann Neurol. 1993 Sep; 34(3):385-93. Joshi the human T-cell receptor beta-chain gene complex is linked to recombination hotspots. Proc Natl Acad Sci U S A. 1993 Jun 01; 90(11):5026-9. Seboun E, Houghton L, therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group. Neurology. 1993 May; 43(5):910-8. Weiner Herndon R, JR, Hauser SL, to the proximal region of the long arm of chromosome 11 and association with CA/GT dinucleotide repeat. Genomics. 1993 May; 16(2):539-41. Lev AA, Rosen DR, Kos C, Clifford E, Landes G, Hauser SL, assessment in MHC 1993; 38(3):193-8. Usuku K, Joshi heavy chain constant region genes in multiple sclerosis sibling pairs. J Neuroimmunol. 1993 Jan; 42(1):113-6. Yu Massacesi placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors. 1993; thread protein in cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol. 1992 Dec; 32(6):733-42. de la multiple sclerosis. Arch Neurol. 1992 Sep; 49(9):923-6. Hauser SL, Doolittle TH, Lopez-Bresnahan M, Shahani B, D, Shih cynomolgus monkeys. Quantitation of T cell responses in peripheral blood. J Clin Invest. 1992 Aug; 90(2):399-404. Massacesi L, Joshi T-cell clones. Immunogenetics. 1992; 36(6):363-8. Rev Immunol. 1992; 11(6):381-93. accumulation in multiple sclerosis white matter tissue. J Neurol Sci. 1991 Jun; 103(2):209-15. Yu JS, Hayashi T, autoimmune demyelination: suppression of experimental allergic May; multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology. 1990 Nov; 40(11):1735-9. Hauser SL, Doolittle TH, Birnbaum G, W, Franklin astrocytes are present in multiple sclerosis plaques. Brain Res. 1989 Dec 18; 504(2):284-8. Kostyk SK, in the human T cell receptor beta gene complex. J Exp Med. 1989 Oct 01; 170(4):1263-70. Seboun E, of antibody responses to the acetylcholine receptor by natural antibodies. Eur J Immunol. 1989 Aug; 19(8):1425-30. Sundblad A, with blood and bone marrow smears an susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex. Cell. 1989 Jun 30; 57(7):1095-100. Seboun E, Robinson MA, Doolittle TH, Ciulla with multiple sclerosis. Neurology. 1989 Feb; 39(2 Pt 1):275-7. Hauser SL, cholestanol and sitosterol in sitosterolemia with xanthomatosis. Effect Clin Invest. 1988 Dec; 82(6):1833-9. Shefer S, Nguyen for DNA purification from peripheral blood. Anal Biochem. 1988 Nov 01; 174(2):485-8. lesion: major histocompatibility and activation antigens. localization of major histocompatibility complex antigens in active multiple sclerosis lesions. Ann N Y Acad Sci. 1988; 540:301-5. the T-cell receptor beta chain in families with multiple sclerosis. Ann N Y Acad Sci. 1988; 540:271-6. Ciulla TA, Robinson MA, Seboun E, TH, biopsies from patients with spinal muscular atrophies inhibit neurite outgrowth from spinal neurons. Neurology. 1987 Aug; Henderson Hauser circulating antibodies against muscle proteins in amyotrophic lateral sclerosis and other neurologic diseases. Neurology. 1986 Dec; Hauser Nov; T-lymphotrophic virus sequences in multiple sclerosis tissue. Nature. 1986 Jul 10-16; 322(6075):176-7. Hauser SL, Aubert C, Burks JS, Kerr the cellular infiltrate in multiple sclerosis lesions. Ann Neurol. 1986 Jun; 19(6):578-87. Hauser SL, Bhan AK, Gilles F, 14-day course of high-dose intravenous cyclophosphamide to alter the progression of amyotrophic lateral sclerosis. Arch Neurol. 1986 Apr; 43(4):383-4. Brown RH, mononuclear cells in active multiple sclerosis functional assessment the T8 subset. Clin Immunol Immunopathol. cells in acute murine experimental allergic encephalomyelitis: selective migration of Lyt-1 cells to the central nervous system is associated with a transient depletion of Lyt-1 cells in peripheral blood. J Immunol. 1984 Dec; 133(6):3037-42. Hauser SL, Bahn AK, Che Immunol. 1984 Nov; 133(5):2288-90. Hauser SL, Weiner HL, cholesterol on hepatic sterol and bile acid metabolism in the rat. J Clin Invest. 1984 Nov; 74(5):1773-81. Shefer S, Hauser S, Salen clinical effects. 1984 demonstration of monoclonal antibodies against normal tissue following infection of mice with reovirus and demonstration of shared antigenicity between virus and lymphocytes. Eur J Immunol. 1984 Jun; 14(6):561-5. Tardieu M, sclerosis. J Weiner HL, Hafler allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation. J Immunol. 1984 Mar; 132(3):1276-81. Hauser SL, Weiner HL, of cyclophosphamide in the treatment of multiple sclerosis. Ann N Y Acad Sci. 1984; 436:373-81. Weiner HL, Hauser subsets in patients with multiple sclerosis. An overview. Ann N Y Acad Sci. 1984; 436:281-93. Weiner HL, Hafler in chronic progressive multiple sclerosis. Design of a clinical trial. Arch Neurol. 1983 Oct 21; 40(11):687-90. Hauser SL, Dawson DM, monoclonal antibodies that identify lymphocytes, monocytes, and the Ia antigen. J Neuroimmunol. 1983 distribution of lymphocyte subsets in peripheral blood of humans. J Immunol. 1983 Sep; 131(3):1178-81. Crary B, Hauser SL, Borysenko M, Kutz I, C, Ault multiple sclerosis: monoclonal antibody analysis and relationship to peripheral blood T-cell active multiple sclerosis: weekly analysis over a six-month period. Ann Neurol. 13(4):418-25. randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, N Engl J Med. 1983 Jan 27; 308(4):173-80. Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Propper RD, SL, Ropper sclerosis: clinical features and demonstration of changes in T cell subsets with disease activity. Ann Neurol. 1982 May; peripheral blood of multiple sclerosis patients: kappa/lambda staining patterns. Ann Neurol. Res. in multiple sclerosis. J Immunol. 1981 Sep; 127(3):1114-7. Hauser SL, retardation: neuropathologic studies performed in four retarded persons with autistic behavior. Arch Neurol. 1980 Dec; 37(12):749-53. Williams Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med. 1980 Jul 17; 303(3):125-9. Reinherz EL, Weiner HL, Hauser SL, acid biosynthesis in man and rat. J Clin Invest. 1976 Apr; 57(4):897-903. Shefer S, Cheng FW, Dayal the infantile autism syndrome. A correlation with temporal lobe disease. Brain. 1975 Dec; 98(4):667-88. Hauser "}